Ethypharm is a specialty pharmaceutical company with European roots, dedicated to addressing specific Central Nervous System (CNS) diseases and conditions, as well as Hospital Injectables. Their commitment lies in providing the right treatment and support to patients suffering from debilitating conditions such as chronic pain or addiction, ensuring they receive the necessary care at the right time.
With a focus on CNS and Hospital Injectables, Ethypharm strives to add value to these areas by continuously developing innovative solutions and expanding their product portfolio. As a rapidly transforming company, they actively seek opportunities to grow their business, enlarge their geographical coverage, and foster partnerships to meet unmet needs in their core areas of expertise.
Generated from the website